Kite, A Gilead Company
Clinical trials sponsored by Kite, A Gilead Company, explained in plain language.
-
Engineered immune cells take on multiple sclerosis and more
Disease control Recruiting nowThis early-phase study tests a new treatment called KITE-363, which uses a patient's own modified immune cells to target and attack harmful immune cells causing nerve damage. It is for people with relapsed or hard-to-treat autoimmune neurologic diseases like multiple sclerosis, m…
Phase: PHASE1 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated May 01, 2026 18:27 UTC
-
Second chance: experimental CAR t therapy offered to patients with no other options
Disease control AVAILABLEThis study gives patients with mantle cell lymphoma or acute lymphoblastic leukemia access to a CAR T-cell therapy (brexucabtagene autoleucel) that didn't pass commercial quality checks but is still considered safe enough for use. Participants must have their own batch of the the…
Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated May 01, 2026 16:00 UTC